Portfolio (Quarterly)
Guide ↗
VR ADVISER, LLC
· CIK 0001615982| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 3,685,448.0 | $120.7M | 5.96% | +1.0M | +37.2% | $32.76 | +154.6% |
| 2 | SVRA | SAVARA INC | Healthcare | 13,740,375.0 | $82.9M | 4.09% | +1.1M | +8.3% | $6.03 | -12.1% |
| 3 | MAZE | MAZE THERAPEUTICS INC | Healthcare | 1,548,569.0 | $64.2M | 3.17% | +318K | +25.8% | $41.43 | -42.4% |
| 4 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 1,000,000.0 | $41.2M | 2.04% | +39K | +4.1% | $41.21 | +91.4% |
| 5 | — | ZURA BIO LTD | — | 5,345,115.0 | $28.0M | 1.38% | +714K | +15.4% | $5.24 | — |
| 6 | VOR | VOR BIOPHARMA INC | Healthcare | 1,943,766.0 | $25.4M | 1.26% | +1.4M | +288.8% | $13.08 | +7.6% |
| 7 | — | CRESCENT BIOPHARMA INC. | — | 2,133,576.0 | $25.3M | 1.25% | +746K | +53.7% | $11.86 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%